Summary: A new multidisciplinary study identifies a molecular connection between fine particulate air pollution (PM2.5) and Lewy body dementia, a severe neurodegenerative disorder. Combining large-scale human epidemiology with animal and molecular experiments, researchers found that PM2.5 exposure promotes the formation of toxic alpha-synuclein aggregates in the brain similar to those observed in patients with Lewy body dementia.
In experimental models, mice exposed chronically to PM2.5 developed brain atrophy, cognitive decline, and widespread alpha-synuclein pathology, while mice lacking alpha-synuclein were protected. The evidence supports air pollution as a potential environmental driver of Lewy body dementia and points to new targets for prevention and drug development.
Key Facts:
- Pollution link: Long-term PM2.5 exposure is associated with increased risk of Lewy body dementia in human hospital data.
- Protein trigger: Airborne fine particles induce toxic alpha-synuclein aggregates in mouse and human brain tissue.
- Therapeutic potential: A distinct PM2.5-related alpha-synuclein strain (PM-PFF) may offer a specific target for future drugs.
Source: Columbia University and Johns Hopkins University research teams
Researchers report their findings in Science, describing convergent human, animal, cellular and molecular evidence linking PM2.5 exposure to Lewy body dementia (LBD). LBD includes dementia with Lewy bodies (DLB) and Parkinson’s disease with dementia (PDD), conditions characterized by the abnormal accumulation of the protein alpha-synuclein into aggregates called Lewy bodies.
The investigation began with an epidemiological analysis of over 56 million U.S. hospital records from 2000 to 2014. Focusing on first-time hospitalizations for alpha-synucleinopathies, researchers estimated long-term PM2.5 exposure using ZIP-code level data. Each interquartile-range increase in PM2.5 concentration in these areas corresponded to a higher risk of Lewy body dementia subtypes: about a 17% greater risk for Parkinson’s disease dementia and roughly a 12% greater risk for dementia with Lewy bodies.
These associations were stronger for LBD subtypes than for Parkinson’s disease without dementia, suggesting a specific vulnerability or pathogenic mechanism that links PM2.5 to cognitive decline and Lewy body formation rather than to motor symptoms alone.
To probe causality and mechanism, the team exposed wild-type mice, alpha-synuclein–knockout mice, and humanized alpha-synuclein transgenic mice to PM2.5 samples on an every-other-day schedule for months. In wild-type mice, chronic PM2.5 exposure caused brain atrophy, neuronal loss, cognitive deficits and wide-ranging alpha-synuclein pathology in brain and peripheral organs, accompanied by tau pathology. In contrast, mice genetically lacking alpha-synuclein showed no significant brain changes, indicating that alpha-synuclein is a central mediator of PM2.5 neurotoxicity.
In genetically susceptible mice carrying a human alpha-synuclein mutation linked to early-onset Parkinson’s disease (hA53T), PM2.5 exposure for five months produced widespread alpha-synuclein aggregates and cognitive decline. Biophysical and biochemical characterization showed these PM2.5-associated aggregates differed structurally from aggregates that form during normal aging.
Further experiments demonstrated that PM2.5 samples collected from different regions—China, Europe and the United States—induced similar alpha-synuclein conformational changes and produced a distinct strain of preformed fibrils (PM-PFF). This PM-PFF strain remained stable through serial passages and exhibited pathogenic features resembling those found in human LBD: faster aggregation, resistance to degradation, enhanced propagation across tissues and increased neurotoxicity.
When PM-PFF material was inoculated into humanized alpha-synuclein mice, it preferentially caused cognitive impairments rather than primarily motor deficits. Brain transcriptome analysis showed that both chronic PM2.5 exposure and PM-PFF inoculation triggered gene expression profiles that closely matched those observed in LBD patients (PDD and DLB), but differed from profiles associated with Parkinson’s disease without dementia. These convergent molecular signatures strengthen the case for an LBD-specific pathogenic axis driven by PM2.5.
Conclusions and implications
Taken together, the study provides robust multimodal evidence linking PM2.5 exposure to Lewy body dementia. The data indicate that PM2.5 can induce a pathogenic alpha-synuclein strain (PM-PFF) that drives cognitive decline and transcriptomic changes characteristic of LBD. Alpha-synuclein appears to be required for these detrimental effects, highlighting its central role in the environmental mechanism identified.
From a public health perspective, the findings underscore air pollution as a modifiable environmental risk factor for neurodegenerative disease. Identifying which PM2.5 components are most harmful will be an important next step to inform regulatory and prevention strategies. From a therapeutic standpoint, the PM-PFF strain represents a potential molecular target for drug development aimed at slowing or preventing LBD progression.
Funding:
This research was supported by the National Institutes of Health (multiple grants), the Helis Foundation, the Parkinson’s Foundation, the American Parkinson’s Disease Association, the Freedom Together Foundation and the Department of Defense.
About this Lewy body dementia research news
Author: Stephanie Berger
Source: Columbia University
Contact: Stephanie Berger, Columbia University
Image: The image is credited to Neuroscience News
Original Research: Open access. “Lewy body dementia promotion by air pollutants” by Xiaobo Mao et al., Science. DOI: 10.1126/science.adu4132
Abstract
Lewy body dementia promotion by air pollutants
INTRODUCTION
Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with dementia (PDD), is an increasingly common and devastating neurodegenerative disorder. Ambient PM2.5 is an established risk factor for dementia broadly, but its specific role in initiating LBD and its distinct pathological trajectory compared with Parkinson’s disease without dementia required systematic investigation.
RATIONALE
Pathologic alpha-synuclein aggregation is the defining neuropathological hallmark of LBD. A major hypothesis is that environmental neurotoxins like fine particulate matter (PM2.5) can trigger alpha-synuclein misfolding and propagation, producing strains that drive LBD-specific pathology. This study set out to test that hypothesis across epidemiologic, animal, molecular and patient-derived data.
RESULTS
Multimodal evidence from a large human dataset, animal models and molecular analyses supports a PM2.5–LBD link. Chronic PM2.5 exposure associated more strongly with first hospitalizations for LBD than for Parkinson’s disease without dementia. In mice, PM2.5 induced brain atrophy, cognitive impairment and widespread alpha-synuclein pathology that depended on alpha-synuclein expression. PM2.5 altered alpha-synuclein conformation to create a persistent, pathogenic strain (PM-PFF) with LBD-like features and with transcriptomic effects aligning with human LBD signatures.
CONCLUSION
This body of evidence identifies PM2.5 as an environmental contributor to Lewy body dementia, operating through alpha-synuclein–mediated mechanisms and generating a distinct pathogenic strain. These findings highlight the need for further research into air pollution’s role in neurodegeneration, targeted efforts to identify harmful PM2.5 components, and exploration of PM-PFF–directed therapeutic strategies.